Kodiak Sciences Stock News & Updates
[WKN: A2N6P0 | Symbol: KOD]
Kodiak Sciences
Kodiak Sciences: Tackling the Global Blindness Threat
Pivotal Point Follow-up Kodiak Sciences (KOD): Strong Phase 3 Study Data in Ophthalmology Triggers a Massive Price Surge
Kodiak Sciences is a US biopharma company that develops novel therapies for the treatment of severe retinal...
Tracking the Pivotal Point of Kodiak Sciences (KOD): Phase 3 Success Represents a Turning Point in Retinal Therapy!
Kodiak Sciences focuses on the development of innovative therapeutics for the treatment of serious eye...
US Markets Deep in Correction due to Middle East Concerns – Dax Slides – Meta Builds Huge AI Data Center for $10 Billion – Netflix Raises Prices for Massive Content Budget – Kodiak Sciences Explodes after Breakthrough in Eye Medication – Unity Software Raises Forecast Thanks to Strong AI Engine
The escalating Middle East conflict keeps investors on Wall Street on edge On the last trading day...
Kodiak Sciences (KOD) in our Pivotal Point Check: Breakthrough in Phase 3 study for Ophthalmology – Biotech Stock Skyrockets by Over 70%!
Positive GLOW2 study results: Zenkuda (Tarcocimab Tedromer) demonstrates high efficacy in diabetic...
Analysts' Top 5 Price Targets of March 27, 2026
PVA TePla [DE0007461006] Deutsche Bank confirms Buy rating and raises the price target from €33...
Kodiak Sciences: The Revolution in Ophthalmology?
Kodiak Sciences is a clinical-stage biopharmaceutical company developing novel therapies for the treatment...
Kodiak Sciences in Focus After Upgrade by J.P. Morgan!
Kodiak Sciences is a biopharmaceutical company based in Palo Alto, California, specializing in the development...
- ‹
- 1
- ›